Drug Type Monoclonal antibody |
Synonyms |
Target- |
Mechanism ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Zumutor Biologics, Inc.Startup |
Active Organization Zumutor Biologics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoma | Preclinical | US | Zumutor Biologics, Inc.Startup | - |